1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Polio Vaccine Consumption 2016-2026

2.1.2 Polio Vaccine Consumption CAGR by Region

2.2 Polio Vaccine Segment by Type

2.2.1 Inactivated Polio Vaccine (IPV)

2.2.2 Oral Polio Vaccine (OPV)

2.3 Polio Vaccine Sales by Type

2.3.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Polio Vaccine Sale Price by Type (2016-2021)

2.4 Polio Vaccine Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Polio Vaccine Sales by Application

2.5.1 Global Polio Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Polio Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Polio Vaccine Sale Price by Application (2016-2021)

3 Global Polio Vaccine by Company

3.1 Global Polio Vaccine Sales Market Share by Company

3.1.1 Global Polio Vaccine Sales by Company (2019-2021)

3.1.2 Global Polio Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Polio Vaccine Revenue Market Share by Company

3.2.1 Global Polio Vaccine Revenue by Company (2019-2021)

3.2.2 Global Polio Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Polio Vaccine Sale Price by Company

3.4 Global Manufacturers Polio Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Polio Vaccine Product Location Distribution

3.4.2 Players Polio Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Polio Vaccine by Region

4.1 Global Polio Vaccine by Region

4.1.1 Global Polio Vaccine Sales by Region

4.1.2 Global Polio Vaccine Revenue by Region

4.2 Americas Polio Vaccine Sales Growth

4.3 APAC Polio Vaccine Sales Growth

4.4 Europe Polio Vaccine Sales Growth

4.5 Middle East & Africa Polio Vaccine Sales Growth

5 Americas

5.1 Americas Polio Vaccine Sales by Country

5.1.1 Americas Polio Vaccine Sales by Country (2016-2021)

5.1.2 Americas Polio Vaccine Revenue by Country (2016-2021)

5.2 Americas Polio Vaccine Sales by Type

5.3 Americas Polio Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Polio Vaccine Sales by Region

6.1.1 APAC Polio Vaccine Sales by Region (2016-2021)

6.1.2 APAC Polio Vaccine Revenue by Region (2016-2021)

6.2 APAC Polio Vaccine Sales by Type

6.3 APAC Polio Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Polio Vaccine by Country

7.1.1 Europe Polio Vaccine Sales by Country (2016-2021)

7.1.2 Europe Polio Vaccine Revenue by Country (2016-2021)

7.2 Europe Polio Vaccine Sales by Type

7.3 Europe Polio Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Polio Vaccine by Country

8.1.1 Middle East & Africa Polio Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Polio Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Polio Vaccine Sales by Type

8.3 Middle East & Africa Polio Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Polio Vaccine Distributors

10.3 Polio Vaccine Customer

11 Global Polio Vaccine Market Forecast

11.1 Global Polio Vaccine Forecast by Region

11.1.1 Global Polio Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Polio Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Polio Vaccine Forecast by Type

11.7 Global Polio Vaccine Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Sanofi Company Information

12.1.2 Sanofi Polio Vaccine Product Offered

12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Polio Vaccine Product Offered

12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Bibcol

12.3.1 Bibcol Company Information

12.3.2 Bibcol Polio Vaccine Product Offered

12.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Bibcol Main Business Overview

12.3.5 Bibcol Latest Developments

12.4 Serum Institute

12.4.1 Serum Institute Company Information

12.4.2 Serum Institute Polio Vaccine Product Offered

12.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Serum Institute Main Business Overview

12.4.5 Serum Institute Latest Developments

12.5 Tiantan Biological

12.5.1 Tiantan Biological Company Information

12.5.2 Tiantan Biological Polio Vaccine Product Offered

12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Tiantan Biological Main Business Overview

12.5.5 Tiantan Biological Latest Developments

12.6 IMBCA

12.6.1 IMBCA Company Information

12.6.2 IMBCA Polio Vaccine Product Offered

12.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 IMBCA Main Business Overview

12.6.5 IMBCA Latest Developments

12.7 Panacea Biotec Ltd

12.7.1 Panacea Biotec Ltd Company Information

12.7.2 Panacea Biotec Ltd Polio Vaccine Product Offered

12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Panacea Biotec Ltd Main Business Overview

12.7.5 Panacea Biotec Ltd Latest Developments

12.8 Bio-Med

12.8.1 Bio-Med Company Information

12.8.2 Bio-Med Polio Vaccine Product Offered

12.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Bio-Med Main Business Overview

12.8.5 Bio-Med Latest Developments

12.9 Halfkin Bio-Pharmaceuticals

12.9.1 Halfkin Bio-Pharmaceuticals Company Information

12.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered

12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview

12.9.5 Halfkin Bio-Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Polio Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Inactivated Polio Vaccine (IPV)

Table 3. Major Players of Oral Polio Vaccine (OPV)

Table 4. Global Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 5. Global Polio Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global Polio Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global Polio Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global Polio Vaccine Sale Price by Type (2016-2021)

Table 9. Global Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 10. Global Polio Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global Polio Vaccine Value by Application (2016-2021)

Table 12. Global Polio Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global Polio Vaccine Sale Price by Application (2016-2021)

Table 14. Global Polio Vaccine Sales by Company (2019-2021) & (M Doses)

Table 15. Global Polio Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global Polio Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Polio Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global Polio Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Polio Vaccine Producing Area Distribution and Sales Area

Table 20. Players Polio Vaccine Products Offered

Table 21. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Polio Vaccine Sales by Region (2016-2021) (M Doses)

Table 25. Global Polio Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global Polio Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Polio Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 29. Americas Polio Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 33. Americas Polio Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 35. Americas Polio Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC Polio Vaccine Sales by Region (2016-2021) & (M Doses)

Table 37. APAC Polio Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC Polio Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Polio Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 41. APAC Polio Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 43. APAC Polio Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 45. Europe Polio Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 49. Europe Polio Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 51. Europe Polio Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 53. Middle East & Africa Polio Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 57. Middle East & Africa Polio Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 59. Middle East & Africa Polio Vaccine Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Polio Vaccine

Table 61. Key Application and Potential Industries of Polio Vaccine

Table 62. Key Challenges of Polio Vaccine

Table 63. Key Trends of Polio Vaccine

Table 64. Polio Vaccine Distributors List

Table 65. Polio Vaccine Customer List

Table 66. Global Polio Vaccine Sales Forecast by Region (2021-2026) & (M Doses)

Table 67. Global Polio Vaccine Consumption Market Forecast by Region

Table 68. Global Polio Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Polio Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 71. Americas Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Polio Vaccine Sales Forecast by Region (2021-2026) & (M Doses)

Table 73. APAC Polio Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 75. Europe Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 77. Middle East & Africa Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Polio Vaccine Sales Forecast by Type (2021-2026) & (M Doses)

Table 79. Global Polio Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Polio Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Polio Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Polio Vaccine Sales Forecast by Application (2021-2026) & (M Doses)

Table 83. Global Polio Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Polio Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Polio Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 86. Sanofi Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 87. Sanofi Polio Vaccine Product Offered

Table 88. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 89. Sanofi Main Business

Table 90. Sanofi Latest Developments

Table 91. GSK Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 92. GSK Polio Vaccine Product Offered

Table 93. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 94. GSK Main Business

Table 95. GSK Latest Developments

Table 96. Bibcol Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. Bibcol Polio Vaccine Product Offered

Table 98. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 99. Bibcol Main Business

Table 100. Bibcol Latest Developments

Table 101. Serum Institute Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Serum Institute Polio Vaccine Product Offered

Table 103. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 104. Serum Institute Main Business

Table 105. Serum Institute Latest Developments

Table 106. Tiantan Biological Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. Tiantan Biological Polio Vaccine Product Offered

Table 108. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 109. Tiantan Biological Main Business

Table 110. Tiantan Biological Latest Developments

Table 111. IMBCA Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 112. IMBCA Polio Vaccine Product Offered

Table 113. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 114. IMBCA Main Business

Table 115. IMBCA Latest Developments

Table 116. Panacea Biotec Ltd Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 117. Panacea Biotec Ltd Polio Vaccine Product Offered

Table 118. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 119. Panacea Biotec Ltd Main Business

Table 120. Panacea Biotec Ltd Latest Developments

Table 121. Bio-Med Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 122. Bio-Med Polio Vaccine Product Offered

Table 123. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 124. Bio-Med Main Business

Table 125. Bio-Med Latest Developments

Table 126. Halfkin Bio-Pharmaceuticals Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 127. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered

Table 128. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 129. Halfkin Bio-Pharmaceuticals Main Business

Table 130. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Polio Vaccine

Figure 2. Polio Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Polio Vaccine Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global Polio Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Polio Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)

Figure 10. Product Picture of Oral Polio Vaccine (OPV)

Figure 11. Global Polio Vaccine Sales Market Share by Type in 2020

Figure 12. Global Polio Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. Polio Vaccine Consumed in Public

Figure 14. Global Polio Vaccine Market: Public (2016-2021) & (M Doses)

Figure 15. Polio Vaccine Consumed in Private

Figure 16. Global Polio Vaccine Market: Private (2016-2021) & (M Doses)

Figure 17. Global Polio Vaccine Sales Market Share by Application (2016-2021)

Figure 18. Global Polio Vaccine Revenue Market Share by Application in 2020

Figure 19. Polio Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2020

Figure 21. Global Polio Vaccine Sales Market Share by Regions (2016-2021)

Figure 22. Global Polio Vaccine Revenue Market Share by Region in 2020

Figure 23. Americas Polio Vaccine Sales 2016-2021 (M Doses)

Figure 24. Americas Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 25. APAC Polio Vaccine Sales 2016-2021 (M Doses)

Figure 26. APAC Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. Europe Polio Vaccine Sales 2016-2021 (M Doses)

Figure 28. Europe Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Polio Vaccine Sales 2016-2021 (M Doses)

Figure 30. Middle East & Africa Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Americas Polio Vaccine Sales Market Share by Country in 2020

Figure 32. Americas Polio Vaccine Revenue Market Share by Country in 2020

Figure 33. Americas Polio Vaccine Sales Market Share by Type in 2020

Figure 34. Americas Polio Vaccine Sales Market Share by Application in 2020

Figure 35. United States Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Polio Vaccine Sales Market Share by Region in 2020

Figure 40. APAC Polio Vaccine Revenue Market Share by Regions in 2020

Figure 41. APAC Polio Vaccine Sales Market Share by Type in 2020

Figure 42. APAC Polio Vaccine Sales Market Share by Application in 2020

Figure 43. China Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Polio Vaccine Sales Market Share by Country in 2020

Figure 50. Europe Polio Vaccine Revenue Market Share by Country in 2020

Figure 51. Europe Polio Vaccine Sales Market Share by Type in 2020

Figure 52. Europe Polio Vaccine Sales Market Share by Application in 2020

Figure 53. Germany Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Polio Vaccine Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Polio Vaccine Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Polio Vaccine Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Polio Vaccine Sales Market Share by Application in 2020

Figure 62. Egypt Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles